The group's principal activity is to develop and manufacture patented and patent pending devices designed to facilitate minimally invasive surgical procedures in interventional cardiology and radiology. The group's devices are designed to make these procedures easier for the doctor to perform, and safer for the patient, by reducing required time in the operating room, speeding up the recovery time, and assisting in eliminating debris that could cause complications. The company is a latter-stage medical device business with a creative corporate culture that encourages its employees to explore product innovations that are intended to improve patient outcomes. Sci-Pro®, Clo-Sur P.A.D.®, Sci-Pro®.
